Investigation of Tumor Microenvironment After CRPC Along With Before and After Neoadjuvant Therapy for Prostate Cancer
Not yet recruitingOBSERVATIONAL
Enrollment
1,000
Participants
Timeline
Start Date
September 1, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Conditions
Prostate Cancer
Trial Locations (1)
710061
First Affiliated Hospital of Xi'an Jiaotong University, Xi'an
All Listed Sponsors
lead
First Affiliated Hospital Xi'an Jiaotong University
OTHER
NCT05522907 - Investigation of Tumor Microenvironment After CRPC Along With Before and After Neoadjuvant Therapy for Prostate Cancer | Biotech Hunter | Biotech Hunter